Last update 21 Nov 2024
Benoxinate Hydrochloride/Fluorescein Sodium
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug, Fluorescent dyes |
Synonyms Altafluor benox |
Target |
Mechanism SCNA modulators(Sodium channel alpha subunit modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (14 Dec 2017), |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC17H29ClN2O3 |
InChIKeyPRGUDWLMFLCODA-UHFFFAOYSA-N |
CAS Registry5987-82-6 |
View All Structures (2)
Related
2
Clinical Trials associated with Benoxinate Hydrochloride/Fluorescein SodiumA Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Used Four Times Daily in a Population of Pediatric, Adult, and Geriatric Subjects
A Single-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Used Four Times Daily in a Population of Adult and Geriatric Subjects With Ocular Redness
100 Clinical Results associated with Benoxinate Hydrochloride/Fluorescein Sodium
Login to view more data
100 Translational Medicine associated with Benoxinate Hydrochloride/Fluorescein Sodium
Login to view more data
100 Patents (Medical) associated with Benoxinate Hydrochloride/Fluorescein Sodium
Login to view more data
1
Literatures (Medical) associated with Benoxinate Hydrochloride/Fluorescein Sodium01 May 1994American Journal of OphthalmologyQ2 · MEDICINE
Potential Bacterial Contamination of Eyedrops Used for Tonometry
Q2 · MEDICINE
Article
Author: Rebecca Palmberg ; Darlene Miller ; Douglas R. Anderson ; William J. Feuer ; Yanet Suarez Gutierrez
100 Deals associated with Benoxinate Hydrochloride/Fluorescein Sodium
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Anesthesia | US | 09 Mar 2020 | |
| Ophthalmologic surgical procedures | US | 14 Dec 2017 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | 507 | (Brimonidine Tartrate) | lgxmoupiar(gbivrbxktu) = falzajhhgd ihzuhvzcvs (pksbkvdcjv, hnmkrxfnuz - dgzkxqphvi) View more | - | 23 Oct 2019 | ||
(Brimonidine Tartrate Vehicle) | lgxmoupiar(gbivrbxktu) = tvkvonxckv ihzuhvzcvs (pksbkvdcjv, lfvhcmjxft - ellkzsyknm) View more | ||||||
Phase 3 | 60 | (Brimonidine Tartrate) | bjwlefeeeb(hpdndrplaw) = ifabauxwme jwxjkmatfl (iahoyekslf, jtwwwlixrz - kkyprhjpez) View more | - | 23 Oct 2019 | ||
(Brimonidine Tartrate Vehicle) | bjwlefeeeb(hpdndrplaw) = eklwrdaick jwxjkmatfl (iahoyekslf, yqdwobvram - plqmarpsdd) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free